Document is current
Any future updates will be listed below
-
Authors
De Martin, Angelina
Stanossek, Yves
Lütge, Mechthild https://orcid.org/0000-0001-9011-5319
Cadosch, Nadine
Onder, Lucas
Cheng, Hung-Wei
Brandstadter, Joshua D. https://orcid.org/0000-0003-0652-5791
Maillard, Ivan https://orcid.org/0000-0003-1312-6748
Stoeckli, Sandro J.
Pikor, Natalia B. https://orcid.org/0000-0002-6564-4232
Ludewig, Burkhard https://orcid.org/0000-0002-7685-573X
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (182583)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (177208)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (180011)
Research Commission of the Kantonsspital St.Gallen grant no. 19/07
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (T32-HL07439)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01-AI091627)
- License Information
-
More Information
Article History
Received: 2 May 2022
Accepted: 3 April 2023
First Online: 18 May 2023
Competing interests
: H.-W.C., L.O., N.B.P. and B.L. are founders and shareholders of Stromal Therapeutics. L.O. and B.L. are members of the board of Stromal Therapeutics. All other authors declare no competing interests.
